Search Results - "Mantel I"

I feel lucky to be in North Carolina: An Interview with Gabrielle Calvocoressi.

Authors: CANTRELL, JAIME

Source: North Carolina Literary Review; 2025, Issue 34, p68-83, 16p

The Art of Fiction No. 226.

Authors: MANTEL, HILARY

Source: Paris Review; Spring2015, Issue 212, p36-71, 36p

Systemic Immune and miRNA Signatures Associated with Long-Term Ranibizumab Response in Neovascular Age-Related Macular Degeneration.

Authors: García-Quintanilla, Laura Almuiña-Varela, Pablo Rodríguez-Cid, María José et al.

Source: Pharmaceuticals (14248247). Jun2026, Vol. 19 Issue 6, p955. 14p.

Author Index.

Source: Acta Ophthalmologica (1755375X). Dec2018 Supplement S261, Vol. 96 Issue 261, p144-150. 7p.

Prevalence of central serous chorioretinopathy in Denmark.

Authors: Frederiksen, Ida N. Muttuvelu, Danson V. Anguita, Rodrigo et al.

Source: Acta Ophthalmologica (1755375X). Nov2025, Vol. 103 Issue 7, p776-781. 6p.

Impact of preocular and ocular circulatory dynamics on the vascular density of retinal capillary plexuses and choriocapillaris.

Authors: Vallée R Körpe D Vallée JN et al.

Source: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefes Arch Clin Exp Ophthalmol] 2024 Dec; Vol. 262 (12), pp. 3867-3879. Date of Electronic Publication: 2024 Jul 31.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 8205248 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-702X (Electronic) Linking ISSN: 0721832X NLM ISO Abbreviation: Graefes Arch Clin Exp Ophthalmol Subsets: MEDLINE

Efficacy of a single dose switch from aflibercept to ranibizumab in the treatment of neovascular age-related macular degeneration.

Authors: Iby, Johannes Coulibaly, Leonard Hollaus, Marlene et al.

Source: PLoS ONE. 3/6/2026, Vol. 21 Issue 3, p1-11. 11p.

Initial Experiences of Switching to Aflibercept 8 mg for Neovascular Age-Related Macular Degeneration and Polypoidal Chorodal Vasculopathy in an Asian Population.

Authors: Cheung, Chui Ming Gemmy Kikushima, Wataru Teo, Kelvin Y. C.

Source: Ophthalmology & Therapy. Mar2026, Vol. 15 Issue 3, p1057-1068. 12p.

Deep Learning–Based Choroidal Boundary Detection in Geographic Atrophy Using Spectral-Domain Optical Coherence Tomography.

Authors: Rahmanipour, Elham Hasan, Nasiq Gadari, Adarsh et al.

Source: Diagnostics (2075-4418). Mar2026, Vol. 16 Issue 5, p737. 14p.

Role of E5 from HPV16 in the Evasion of the Immune Response.

Authors: Pérez-Morales, Aislinn C. Maldonado-Gama, Minerva Méndez-Armenta, Marisela et al.

Source: International Journal of Molecular Sciences. Feb2026, Vol. 27 Issue 4, p1985. 15p.

Early Outcomes of Intravitreal Aflibercept 8 mg in Eyes Previously Treated with Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration with AI-Based Biomarker Quantification.

Authors: Bartolomeo, Nicolò Kalyvianakis, Konstantinos Kitsos Schuetz, Yannic Pannatier et al.

Source: Ophthalmology & Therapy. Feb2026, Vol. 15 Issue 2, p831-842. 12p.

SRF and SHRM in nAMD: Retrospective Analysis of Visual Prognosis.

Authors: Wu, Weizhen Guo, Huiling Wang, Luping et al.

Source: Clinical Ophthalmology. Feb2026, Vol. 20, p1-8. 8p.

Faricimab at 6 and 12 mg reduces pigment epithelium detachment in treatment-resistant macular neovascularization: an OCT and AI analysis.

Authors: Nagel, Ines D. Tran, Melanie D. Zhang, Haochen et al.

Source: Scientific Reports. 9/30/2025, Vol. 15 Issue 1, p1-8. 8p.

High-Resolution Adaptive Optics Transscleral Flood Illumination Imaging Allows Phenotyping of Age-Related Macular Degeneration †.

Authors: Mohanna, Safa Eppenberger, Leila S. Pfäffli, Oliver et al.

Source: Cells (2073-4409). Sep2025, Vol. 14 Issue 17, p1308. 13p.

Long-term outcomes of the observe-and-plan regimen in treating neovascular age-related macular degeneration: a retrospective real-life analysis.

Authors: Sherif M Derradji Y Safi A et al.

Source: Eye (London, England) [Eye (Lond)] 2025 Aug; Vol. 39 (11), pp. 2188-2193. Date of Electronic Publication: 2025 May 10.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8703986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5454 (Electronic) Linking ISSN: 0950222X NLM ISO Abbreviation: Eye (Lond) Subsets: MEDLINE

Comparative efficacy of intravitreal anti‐VEGF therapy for neovascular age‐related macular degeneration: A systematic review with network meta‐analysis.

Authors: Butler, Emilie T. S. Arnold‐Vangsted, Andreas Schou, Marianne G. et al.

Source: Acta Ophthalmologica (1755375X). Nov2025, Vol. 103 Issue 7, p741-763. 23p.

Successful management of a massive subretinal hemorrhage with intravitreal t-PA, perfluoropropane, and bevacizumab: a case report.

Authors: El Arari, Nihal Benchekroun, Saad Hamidi, Salma et al.

Source: Pan African Medical Journal. 2025, Vol. 51, p1-8. 8p.

Detection and Management of Geographic Atrophy Secondary to Age-Related Macular Degeneration Using Noninvasive Retinal Images and Artificial Intelligence: Systematic Review.

Authors: Shi, Nannan Li, Jiaxian Shang, Mengqiu et al.

Source: Journal of Medical Internet Research. 2025, Vol. 27, p1-39. 39p.

Efficacy and Safety of Biosimilar QL1207 vs. the Reference Aflibercept for Patients with Neovascular Age-Related Macular Degeneration: A Randomized Phase 3 Trial.

Authors: Li, Bing Fan, Ke Zhang, Tonghe et al.

Source: Ophthalmology & Therapy. Jan2024, Vol. 13 Issue 1, p353-366. 14p.

A genome-wide association study of adults with community-acquired pneumonia.

Authors: Suarez-Pajes, Eva Marcelino-Rodriguez, Itahisa Hernández Brito, Elisa et al.

Source: Respiratory Research. 10/16/2024, Vol. 25 Issue 1, p1-9. 9p.